바로가기메뉴

본문 바로가기 주메뉴 바로가기

ACOMS+ 및 학술지 리포지터리 설명회

  • 한국과학기술정보연구원(KISTI) 서울분원 대회의실(별관 3층)
  • 2024년 07월 03일(수) 13:30
 

logo

메뉴

보툴리눔 톡신 주사를 위한 깨물근 얕은층의 임상해부학적 고찰

Clinical anatomic consideration of the superficial layer of the masseter muscle for botulinum toxin injection

Abstract

In clinical dentistry, botulinum toxin is generally used to treat the square jaw, bruxism, and temporomandibular joint diseases. Recently, this procedure has been expanded and applied for cosmetic purposes, and it is becoming a key task to be aware of the precise anatomical structure of the target muscles to be cautious during treatment and how to prevent side effects. Therefore, the purpose of this study is to observe the anatomical structure of the superficial layer of masseter muscle and to provide a most effective botulinum toxin injection method through clinical anatomical consideration. It was observed that the muscle belly of superficial part of the superficial layer was originated from the deep to the aponeurosis of masseter muscle and descend, then changed gradually into the tendon structure attaching to the inferior border of the mandible. In this study, we named this structure deep inferior tendon. This structure was observed in all specimens. We conclude that the use of superficial layer and deep layer injection should be considered to prevent paradoxical masseteric bulging in consideration of the deep inferior tendon of superficial part of superficial layer of masseter muscle.

keywords
Masseter muscle, tendinous structure, botulinum neurotoxin type A injection, masseteric bulging

참고문헌

1.

1. Lee HJ. The Anatomical Basis of Paradoxical Masseteric Bulging after Botulinum Neurotoxin Type A Injection. TOXINS 2017; 9(1):14.

2.

2. Ahn DS. The reality and problems of CME. Healthcare Policy Forum 2006; 4:142-147.

3.

3. Lee MS. Embodiment of CPD and Professionalism. Yonsei Journal of Medical Education 2004; 6:45-52.

4.

4. Research Institute for Healthcare Policy. Research on actual condition of CPD program and reformation. 2003. Research Institute for Healthcare Policy.

5.

5. Kim YI. Balancing of pre-and post-Institutional medical education revisited: recommendation for strengthening of continuing medical education in the institution-based undergraduate education. Kor J Med Educ 1995; 7:177-185.

6.

6. Kim YI. Current status and issues of Korean CPD. CPD Strategies in Internet Era-Symposium material. November 16, 2001. The Korean Society of Medical Informatics, The Korean Society of Medical Education, 2001:5.

7.

7. Son MS. Doctors' professionalism and policy. 14th Medical Education Conference material:Professionalism in Medical Education. The Korean Society of Medical Education, Korean Academy of Medical Sciences 2003; 107-114.

8.

8. Lee YS. Comparison of national and international medical license. Medical License Reinforcement Scheme for medical Personnel Quality Development Forum material. December 16, 2003. Ministry for Health, Korean Academy of Medical Sciences 2003;1-45.

9.

9. Chung BT. Quality improvement policy of medical personnel. Establishing Commemoration Symposium material of the Korean Institute of Medical Education and Evaluation: Medical Professionalism and Social Responsibility. Korean Institute of Medical Education and Evaluation 2004; 7-12.

10.

10. Kim YI. Continuing medical education in Korea. Issues and prospects. Intercountry Symposium on Postgraduate and Continuing Medical Education for Primary Health Care. World Health Organization Regional Office for the Western Pacific, WPR/HRH(1), 1990; 90:3.

11.

11. 우리몸 해부그림 (1st Edition Atlas of Human Anatomy), 대한해부학회, 현문사, 2009.

12.

12. Kim DH. Intramuscular nerve distribution of the masseter muscle as a basis for botulinum toxin injection. Journal of Craniofacial Surgery. 2010;21(2):588-591.

13.

13. Clinical Anatomy of the Face for Filler and Botulinum Toxin Injection, Kim HJ, Springer, 2015.

logo